Key Takeaways
- • The Barclays Hedge Fund Index posted a gain of 0.37% in June 2017, marking the sixth consecutive monthly advance for the benchmark index.
- • Year-to-date performance reached 4.41% as of June, demonstrating sustained positive momentum for the broader hedge fund industry through mid-2017.
- • Healthcare and Biotechnology emerged as the strongest performing subcategory, delivering a 5.32% gain in June, leading all 17 tracked subindices.
- • Thirteen of 17 subindices recorded positive returns during the month, indicating broad-based strength across hedge fund strategy categories.
Summary
The Barclays Hedge Fund Index recorded a 0.37% gain in June 2017, continuing an extended winning streak for hedge fund performance. The monthly advance represented the sixth consecutive positive return for the benchmark, reflecting sustained recovery and positive momentum across the alternative investment space during the first half of 2017.
Year-to-date performance through June reached 4.41%, signaling solid accumulated returns for hedge fund investors during the period. This performance trajectory reflects a constructive market environment characterized by improved risk appetite and stability in global financial conditions.
Sector-level performance was notably strong, with Healthcare and Biotechnology leading all tracked subindices by a substantial margin. The sector delivered a 5.32% gain in June alone, significantly outpacing the broad index return. The outperformance of healthcare-focused strategies reflects thematic strength in those industries during the period.
Breadth of gains remained robust, with 13 of 17 subindices posting positive returns in June. This wide distribution of positive performance across strategy categories—rather than gains concentrated in a single area—suggests underlying strength in hedge fund positioning and market conditions rather than isolated sector rallies. The consistent performance across multiple subindices provides institutional investors with evidence of balanced risk dynamics across the hedge fund landscape during mid-2017.
Year-to-date performance through June reached 4.41%, signaling solid accumulated returns for hedge fund investors during the period. This performance trajectory reflects a constructive market environment characterized by improved risk appetite and stability in global financial conditions.
Sector-level performance was notably strong, with Healthcare and Biotechnology leading all tracked subindices by a substantial margin. The sector delivered a 5.32% gain in June alone, significantly outpacing the broad index return. The outperformance of healthcare-focused strategies reflects thematic strength in those industries during the period.
Breadth of gains remained robust, with 13 of 17 subindices posting positive returns in June. This wide distribution of positive performance across strategy categories—rather than gains concentrated in a single area—suggests underlying strength in hedge fund positioning and market conditions rather than isolated sector rallies. The consistent performance across multiple subindices provides institutional investors with evidence of balanced risk dynamics across the hedge fund landscape during mid-2017.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.